Amedisys (AMED) Moves to Highs of Session Following Better-than-Expected Results
Amedisys (NASDAQ: AMED) is gaining momentum amid today's stronger-than-expected Q2 results. Shares are now up 17% on heavy volume.Amedisys ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
